ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
45 announcements
Yatharth delivered record performance driven by newer acquisitions turning EBITDA positive and a strategic 3,150 Cr Advent partnership to double bed capacity.
Q2 FY27 revenue Rs 4,314 mn (+52% YoY), EBITDA Rs 1,020 mn (23.6% margin), PAT Rs 485 mn (+17% YoY). Advent Rs 3,150 cr primary infusion awaits approvals.
Yatharth Hospitals reported a 52% YoY revenue growth to Rs 4,314 million for Q2 FY27. The company also announced a Rs 3,150 crore strategic investment from Advent International.
Yatharth Hospital & Trauma Care Services Ltd reported revenue from operations of ₹431.4 Cr (+52.4% YoY) and net profit of ₹48.5 Cr (+17.4% YoY) for Q2 FY27.
Yatharth Hospital intimated that its Board will meet on 3 Nov 2026 to consider Q2 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
Yatharth Hospital & Trauma Care Services Ltd announced the voting results for its Extraordinary General Meeting held on October 15, 2026, where all five resolutions passed.
Yatharth Hospital's EGM approved increasing authorized share capital, issuing subscription securities (equity shares and warrants) via preferential placement, and amending articles of association.
Yatharth Hospital & Trauma Care Services Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Yatharth Hospital & Trauma Care Services issued a corrigendum to the EGM notice dated September 22, 2026, regarding its proposed preferential issue of equity shares and warrants.
Yatharth Hospital issued an EGM notice for October 15, 2026. Agenda items include a preferential issue and authorized capital increase.
Yatharth Hospital convened an EGM to approve increasing its authorized share capital and a preferential issue of equity shares and warrants aggregating to ₹1,283.33 Crore.
Yatharth Hospital & Trauma Care Services Limited is increasing its authorized share capital to facilitate a preferential issue of equity shares and warrants.
Yatharth Hospital approved a preferential issue of 3.2 crore equity shares and warrants to Rasmalai Limited for ₹3,150.00 Crore, subject to shareholder approval.
Yatharth Hospital's Board approved a ₹3,150 Crore preferential issue to Cyprus-based Rasmalai Limited. The EGM will seek shareholder approval on October 15, 2026.
Yatharth Hospital announced a board meeting scheduled for September 17, 2026, to discuss and consider proposals for raising funds.
Yatharth Hospital and its subsidiaries received income tax assessment orders totaling Rs. 41.08 crore in demand and interest, which they plan to appeal.
Yatharth Hospital & Trauma Care Services Limited issued a notice for its 19th Annual General Meeting scheduled for September 25, 2026.
Yatharth Hospital clarified regarding a news report about potential stake acquisition, stating no undisclosed information exists requiring disclosure under SEBI Listing Regulations.
Yatharth Hospital & Trauma Care Services Limited has scheduled its 19th Annual General Meeting to be held on September 25, 2026, through video conferencing.
Yatharth Hospital submitted its Monitoring Agency Report for Q1 FY27. CARE Ratings Limited confirmed no deviations in use of the Rs. 610 Crore IPO proceeds.
Yatharth Hospital delivered record quarterly revenue, driven by rapid scaling of new facilities and high ARPOB at premium NCR centers. Management remains aggressively expansionist with significant capacity additions planned.
Yatharth Hospital re-appointed M/s. Subodh Kumar & Co. as Cost Auditors for a 12-month term following its board meeting.
Yatharth Hospital & Trauma Care Services re-appointed Subodh Kumar & Co. as Cost Auditors for a 12-month term, effective August 10, 2026.
Yatharth Hospital declared a first interim dividend of ₹0.50 per share. The record date for determining shareholder entitlement is August 14, 2026.
Yatharth reported record Q1FY27 performance with Rs 3,927 mn revenue, driven by aggressive inorganic scaling and occupancy gains. Strategy focuses on high-ARPOB cluster density in NCR and medical value travel.
Yatharth Hospital reported Q1FY27 revenue of Rs 392.7 Crore and PAT of Rs 45.4 Crore. The company also declared a maiden interim dividend for shareholders.
Yatharth Hospital & Trauma Care Services Ltd reported revenue from operations of ₹392.7 Cr (+51.5% YoY) and net profit of ₹45.4 Cr (+8.1% YoY) for Q1 FY27.
Yatharth Hospital & Trauma Care Services granted 250,000 stock options to eligible employees at an exercise price of ₹10 per share. The grant follows the Company's 2024 ESOP scheme.
Yatharth Hospital & Trauma Care Services scheduled a board meeting for August 10, 2026. The board will consider Q1 results, an interim dividend, and an ESOP scheme.
Yatharth Hospital & Trauma Care Services Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026. The filing discloses the current shareholder distribution.